# COVID-19 and Hereditary Metabolic Diseases

> **NCT04645498** · — · UNKNOWN · sponsor: **University Hospital, Lille** · enrollment: 77 (estimated)

## Conditions studied

- Covid19
- Metabolism, Inborn Errors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04645498
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-01
- **Primary completion:** 2023-02
- **Final completion:** 2023-02
- **Target enrollment:** 77 (ESTIMATED)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04645498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04645498, "COVID-19 and Hereditary Metabolic Diseases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04645498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*